14 results on '"Nuzzo, Domenico"'
Search Results
2. Long-Term Ingestion of Sicilian Black Bee Chestnut Honey and/or D-Limonene Counteracts Brain Damage Induced by High Fat-Diet in Obese Mice.
- Author
-
Terzo, Simona, Calvi, Pasquale, Nuzzo, Domenico, Picone, Pasquale, Allegra, Mario, Mulè, Flavia, and Amato, Antonella
- Subjects
HONEYBEES ,BRAIN damage ,HIGH-fat diet ,INGESTION ,ALZHEIMER'S disease ,AMYLOID plaque - Abstract
Obesity is linked to neurodegeneration, which is mainly caused by inflammation and oxidative stress. We analyzed whether the long-term intake of honey and/or D-limonene, which are known for their antioxidant and anti-inflammatory actions, when ingested separately or in combination, can counteract the neurodegeneration occurring in high fat diet (HFD)-induced obesity. After 10 weeks of HFD, mice were divided into: HFD-, HFD + honey (HFD-H)-, HFD + D-limonene (HFD-L)-, HFD + honey + D-limonene (HFD-H + L)-fed groups, for another 10 weeks. Another group was fed a standard diet (STD). We analyzed the brain neurodegeneration, inflammation, oxidative stress, and gene expression of Alzheimer's disease (AD) markers. The HFD animals showed higher neuronal apoptosis, upregulation of pro-apoptotic genes Fas-L, Bim P27 and downregulation of anti-apoptotic factors BDNF and BCL2; increased gene expression of the pro-inflammatory IL-1β, IL-6 and TNF-α and elevated oxidative stress markers COX-2, iNOS, ROS and nitrite. The honey and D-limonene intake counteracted these alterations; however, they did so in a stronger manner when in combination. Genes involved in amyloid plaque processing (APP and TAU), synaptic function (Ache) and AD-related hyperphosphorylation were higher in HFD brains, and significantly downregulated in HFD-H, HFD-L and HFD-H + L. These results suggest that honey and limonene ingestion counteract obesity-related neurodegeneration and that joint consumption is more efficacious than a single administration. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Glucagon-like peptide-2 reduces the obesity-associated inflammation in the brain.
- Author
-
Nuzzo, Domenico, Baldassano, Sara, Amato, Antonella, Picone, Pasquale, Galizzi, Giacoma, Caldara, Gaetano Felice, Di Carlo, Marta, and Mulè, Flavia
- Subjects
- *
GLUCAGON-like peptides , *OBESITY , *INFLAMMATION , *NEURODEGENERATION , *HIGH-fat diet , *OXIDATIVE stress - Abstract
Abstract Growing evidence suggests a link between obesity and neurodegeneration. The purpose of the present study was to explore the neuroprotective potential of glucagon-like peptide-2 (GLP-2) in the brain of high fat diet (HFD)-fed mice. Markers of inflammation and oxidative stress were analysed in the brains of obese mice chronically treated with [Gly2]-GLP-2 (teduglutide), the stable analogue of the GLP-2, and they were compared to age-matched untreated obese and lean animals. Neurodegeneration was examined by TUNEL assay. HFD feeding increased the expression of pro-inflammatory mediators (NF-kB, IL-8, TNF-α, IL-1β and IL-6), glial fibrillary acidic protein (GFAP), index of gliosis and neurodegeneration, stress marker proteins (p-ERK, Hsp60 and i-NOS), amyloid-β precursor protein (APP). [Gly2]-GLP-2 treatment significantly attenuated the HFD-induced increased expression of the various markers, as well as the higher levels of reactive oxygen species found in brains of untreated-HFD mice. Immunofluorescence confirmed that the increase of GFAP or APP in the brain cortex of HFD mice were less prominent in the [Gly2]-GLP-2 treated group. TUNEL-positive cell number in brain sections of [Gly2]-GLP-2-treated HFD-fed mice was significantly lesser in comparison with untreated-HFD animals and similar to STD fed mice. In conclusion, the results of the present study suggest that GLP-2 stable analogue improves the obesity-associated neuroinflammation and the central stress conditions, it reduces the neuronal apoptotic death, providing evidence for a neuroprotective role of the peptide. Highlights • [Gly2]-GLP-2 prevents the increased expression of inflammatory mediators and GFAP in brains of mice with diet-induced obesity. • The peptide reduces the increase in the expression of stress marker proteins) and amyloid-β precursor protein. • TUNEL-positive cell number in brain sections of [Gly2]-GLP-2-treated obese mice is lesser than untreated obese animals. • GLP-2 stable analogue improves the obesity-associated neuroinflammation and the central stress conditions and apoptosis. • GLP-2 could play a neuroprotective role. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Inflammatory Mediators as Biomarkers in Brain Disorders.
- Author
-
Nuzzo, Domenico, Picone, Pasquale, Caruana, Luca, Vasto, Sonya, Barera, Annalisa, Caruso, Calogero, and Carlo, Marta
- Subjects
- *
INFLAMMATORY mediators , *BIOMARKERS , *DIAGNOSIS of brain diseases , *NEURODEGENERATION , *ALZHEIMER'S disease , *PARKINSON'S disease , *AMYOTROPHIC lateral sclerosis - Abstract
Neurodegenerative diseases such as Alzheimer, Parkinson, amyotrophic lateral sclerosis, and Huntington are incurable and debilitating conditions that result in progressive death of the neurons. The definite diagnosis of a neurodegenerative disorder is disadvantaged by the difficulty in obtaining biopsies and thereby to validate the clinical diagnosis with pathological results. Biomarkers are valuable indicators for detecting different phases of a disease such as prevention, early onset, treatment, progression, and monitoring the effect of pharmacological responses to a therapeutic intervention. Inflammation occurs in neurodegenerative diseases, and identification and validation of molecules involved in this process could be a strategy for finding new biomarkers. The ideal inflammatory biomarker needs to be easily measurable, must be reproducible, not subject to wide variation in the population, and unaffected by external factors. Our review summarizes the most important inflammation biomarkers currently available, whose specificity could be utilized for identifying and monitoring distinctive phases of different neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
5. Preventive Impact of Long-Term Ingestion of Chestnut Honey on Glucose Disorders and Neurodegeneration in Obese Mice.
- Author
-
Terzo, Simona, Calvi, Pasquale, Nuzzo, Domenico, Picone, Pasquale, Galizzi, Giacoma, Caruana, Luca, Di Carlo, Marta, Lentini, Laura, Puleio, Roberto, Mulè, Flavia, and Amato, Antonella
- Abstract
The purpose of the present study was to evaluate the impact of long-term honey ingestion on metabolic disorders and neurodegeneration in mice fed a high-fat diet (HFD). Three groups of mice were fed with a standard diet (STD), HFD or HFD supplemented with honey (HFD-H) for 16 weeks. Biochemical, histological, Western blotting, RT-PCR and Profiler PCR array were performed to assess metabolic parameters, peripheral and central insulin resistance and neurodegeneration. Daily honey intake prevented the HFD-induced glucose dysmetabolism. In fact, it reduced plasma fasting glucose, insulin and leptin concentrations and increased adiponectin levels. It improved glucose tolerance, insulin sensitivity and HOMA index without affecting plasma lipid concentration. HFD mice showed a significantly higher number of apoptotic nuclei in the superficial and deep cerebral cortex, upregulation of Fas-L, Bim and P27 (neuronal pro-apoptotic markers) and downregulation of Bcl-2 and BDNF (anti-apoptotic factors) in comparison with STD- and HFD-H mice, providing evidence for honey neuroprotective effects. PCR-array analysis showed that long-term honey intake increased the expression of genes involved in insulin sensitivity and decreased genes involved in neuroinflammation or lipogenesis, suggesting improvement of central insulin resistance. The expressions of p-AKT and p-GSK3 in HFD-H mice, which were decreased and increased, respectively, in HFD mouse brain, index of central insulin resistance, were similar to STD animals supporting the ability of regular honey intake to protect brain neurons from insulin resistance. In conclusion, the present results provide evidence for the beneficial preventative impact of regular honey ingestion on neuronal damage caused by HFD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Promising Treatment for Multiple Sclerosis: Mitochondrial Transplantation.
- Author
-
Picone, Pasquale and Nuzzo, Domenico
- Subjects
- *
MULTIPLE sclerosis , *MITOCHONDRIA , *THERAPEUTICS , *NEURODEGENERATION , *DEMYELINATION - Abstract
In recent years, several studies have examined the multifaceted role of mitochondria in Multiple Sclerosis (MS), suggesting that, besides inflammation and demyelination, mitochondrial aberration is a crucial factor in mediating axonal degeneration, the latter being responsible for persistent disabilities in MS patients. Therefore, mitochondria have been recognized as a possible multiple sclerosis therapeutic target. Recently, mitochondrial transplantation has become a new term for the transfer of live mitochondria into damaged cells for the treatment of various diseases, including neurodegenerative diseases. In this hypothesis, we propose mitochondrial transplantation as a new, potentially applicable approach to counteract axonal degeneration in multiple sclerosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?
- Author
-
Di Carlo, Marta, Giacomazza, Daniela, Picone, Pasquale, Nuzzo, Domenico, and San Biagio, Pier Luigi
- Subjects
OXIDATIVE stress ,MITOCHONDRIA ,MITOCHONDRIAL pathology ,NEURODEGENERATION ,ALZHEIMER'S disease ,PARKINSON'S disease ,AMYOTROPHIC lateral sclerosis - Abstract
Oxidative stress has long been linked to neuronal cell death that is associated with certain neurodegenerative conditions. Whether it is a primary cause or merely a downstream consequence of the neurodegenerative and aging process is still an open question. Mitochondria are deeply involved in the production of reactive oxygen species through the electron carriers of the respiratory chain and their role in neurodegenerative diseases is discussed here. Moreover, the input of new technological approaches in the study of oxidative stress response or in the evidence of an oxidative stress component in neurodegeneration is reviewed in this paper. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. Protective, Antioxidant and Antiproliferative Activity of Grapefruit IntegroPectin on SH-SY5Y Cells.
- Author
-
Nuzzo, Domenico, Scordino, Miriana, Scurria, Antonino, Giardina, Costanza, Giordano, Francesco, Meneguzzo, Francesco, Mudò, Giuseppa, Pagliaro, Mario, Picone, Pasquale, Attanzio, Alessandro, Raimondo, Stefania, Ciriminna, Rosaria, and Di Liberto, Valentina
- Subjects
- *
GRAPEFRUIT , *INHIBITION of cellular proliferation , *PECTINS , *ANTIOXIDANTS , *MEMBRANE potential , *NARINGIN - Abstract
Tested in vitro on SH-SY5Y neuroblastoma cells, grapefruit IntegroPectin is a powerful protective, antioxidant and antiproliferative agent. The strong antioxidant properties of this new citrus pectin, and its ability to preserve mitochondrial membrane potential and morphology, severely impaired in neurodegenerative disorders, make it an attractive therapeutic and preventive agent for the treatment of oxidative stress-associated brain disorders. Similarly, the ability of this pectic polymer rich in RG-I regions, as well as in naringin, linalool, linalool oxide and limonene adsorbed at the outer surface, to inhibit cell proliferation or even kill, at high doses, neoplastic cells may have opened up new therapeutic strategies in cancer research. In order to take full advantage of its vast therapeutic and preventive potential, detailed studies of the molecular mechanism involved in the antiproliferative and neuroprotective of this IntegroPectin are urgently needed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Regular Intake of Pistachio Mitigates the Deleterious Effects of a High Fat-Diet in the Brain of Obese Mice.
- Author
-
Nuzzo, Domenico, Galizzi, Giacoma, Amato, Antonella, Terzo, Simona, Picone, Pasquale, Cristaldi, Laura, Mulè, Flavia, and Di Carlo, Marta
- Subjects
PISTACHIO ,SUPEROXIDE dismutase ,HEME oxygenase ,CEREBRAL cortex ,REACTIVE oxygen species ,HIGH-fat diet ,LIPID metabolism ,CHOLESTEROL content of food - Abstract
Obesity has been associated with neurodegeneration and cognitive dysfunctions. Recent data showed that pistachio consumption is able to prevent and ameliorate dyslipidemia, hepatic steatosis, systemic and adipose tissue inflammation in mice fed a high-fat diet (HFD). The present study investigated the neuroprotective effects of pistachio intake in HFD mice. Three groups of mice were fed a standard diet (STD), HFD, or HFD supplemented with pistachio (HFD-P) for 16 weeks. Metabolic parameters (oxidative stress, apoptosis, and mitochondrial dysfunction) were analyzed by using specific assays and biomarkers. The pistachio diet significantly reduced the serum levels of triglycerides and cholesterol in the HFD model. No difference was observed in the index of insulin resistance between HFD and HFD-P. A higher number of fragmented nuclei were found in HFD cerebral cortex compared to STD and HFD-P. A decrease in reactive oxygen species, singlet oxygen and phosphorylated extracellular signal-regulated kinase, and an increase of superoxide dismutase 2 and heme oxygenase expression were found in the brains of the HFD-P samples compared to HFD. Furthermore, the impaired mitochondrial function found in HFD brain was partially recovered in HFD-P mice. These results suggest that the regular intake of pistachio may be useful in preventing obesity-related neurodegeneration, being able to reduce both metabolic and cellular dysfunctions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. A Natural Dietary Supplement with a Combination of Nutrients Prevents Neurodegeneration Induced by a High Fat Diet in Mice.
- Author
-
Nuzzo, Domenico, Picone, Pasquale, Galizzi, Giacoma, Di Carlo, Marta, Amato, Antonella, Terzo, Simona, Mulè, Flavia, and Bonina, Francesco Paolo
- Abstract
Obesity and metabolic disorders can be risk factors for the onset and development of neurodegenerative diseases. The aim of the present study was to investigate the protective effects of a natural dietary supplement (NDS), containing Curcuma longa, silymarin, guggul, chlorogenic acid and inulin, on dysmetabolism and neurodegeneration in the brains of high fat diet (HFD)-fed mice. Decrease in the expression of FACL-4, CerS-1, CerS-4, cholesterol concentration and increase in the insulin receptor expression and insulin signaling activation, were found in brains of NDS-treated HFD brains in comparison with HFD untreated-mice, suggesting that NDS is able to prevent brain lipid accumulation and central insulin resistance. In the brains of NDS-treated HFD mice, the levels of RNS, ROS and lipid peroxidation, the expression of p-ERK, H-Oxy, i-NOS, HSP60, NF-kB, GFAP, IL-1β, IL-6 and CD4 positive cell infiltration were lower than in untreated HFD mice, suggesting antioxidant and anti-inflammatory effects of NDS. The decreased expression of p-ERK and GFAP in NDS-treated HFD mice was confirmed by immunofluorescence. Lastly, a lower number of apoptotic nuclei was found in cortical sections of NDS-treated HFD mice. The present data indicate that NDS exerts neuroprotective effects in HFD mice by reducing brain fat accumulation, oxidative stress and inflammation and improving brain insulin resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Altered insulin pathway compromises mitochondrial function and quality control both in in vitro and in vivo model systems.
- Author
-
Galizzi, Giacoma, Palumbo, Laura, Amato, Antonella, Conigliaro, Alice, Nuzzo, Domenico, Terzo, Simona, Caruana, Luca, Picone, Pasquale, Alessandro, Riccardo, Mulè, Flavia, and Di Carlo, Marta
- Subjects
- *
INSULIN , *QUALITY control , *INSULIN resistance , *PARKIN (Protein) , *MITOCHONDRIA - Abstract
Schematic representation of the effect of altered insulin signaling on the different aspects of mitochondrial dysfunction and neurodegeneration, by using both in vitro and in vivo model systems. [Display omitted] • Altered insulin pathway induces mitochondrial dysfunction both in vivo and in vitro model systems. • Altered insulin pathway affects mitochondrial dynamics. • Insulin administration ameliorates mitochondrial dysfunction and apoptosis. • Effective mitophagy is an aging-dependent mechanism. Altered insulin signaling and insulin resistance are considered the link between Alzheimer's disease (AD) and metabolic syndrome. Here, by using an in vitro and an in vivo model, we investigated the relationship between these disorders focusing on neuronal mitochondrial dysfunction and mitophagy. In vitro Aβ insult induced the opening of mitochondrial permeability transition pore (mPTP), mitochondrial membrane potential (ΔΨm) loss, and apoptosis while insulin addition ameliorated these dysfunctions. The same alterations were detected in a 16 weeks of age mouse model of diet-induced obesity and insulin resistance. In addition, we detected an increase of fission related proteins and activation of mitophagy, proved by the rise of PINK1 and Parkin proteins. Nevertheless, in vitro, the increase of p62 and LC3 indicated an alteration in autophagy, while, in vivo decreased expression of p62 and increase of LC3 suggested removing of damaged mitochondria. Finally, in aged mice (28 and 48 weeks), the data indicated impairment of mitophagy and suggested the accumulation of damaged mitochondria. Taken together these outcomes indicate that alteration of the insulin pathway affects mitochondrial integrity, and effective mitophagy is age-dependent. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Protective, antioxidant and antiproliferative activity of grapefruit integropectin on sh-sy5y cells
- Author
-
Valentina Di Liberto, Domenico Nuzzo, Costanza Giardina, Francesco Meneguzzo, Antonino Scurria, Miriana Scordino, Mario Pagliaro, Francesco Giordano, Giuseppa Mudò, Stefania Raimondo, Rosaria Ciriminna, Alessandro Attanzio, Pasquale Massimo Picone, Nuzzo, Domenico, Scordino, Miriana, Scurria, Antonino, Giardina, Costanza, Giordano, Francesco, Meneguzzo, Francesco, Mudò, Giuseppa, Pagliaro, Mario, Picone, Pasquale, Attanzio, Alessandro, Raimondo, Stefania, Ciriminna, Rosaria, and Di Liberto, Valentina
- Subjects
SH-SY5Y ,Antioxidant ,Cell Survival ,QH301-705.5 ,medicine.medical_treatment ,Mitochondrion ,Pharmacology ,medicine.disease_cause ,anticancer ,Neuroprotection ,Settore BIO/09 - Fisiologia ,Antioxidants ,Article ,Catalysis ,Inorganic Chemistry ,Neuroblastoma ,chemistry.chemical_compound ,X-Ray Diffraction ,Cell Line, Tumor ,hydrodynamic cavitation ,medicine ,Humans ,oxidative stress ,Physical and Theoretical Chemistry ,Biology (General) ,neurological disease ,Molecular Biology ,Naringin ,QD1-999 ,Spectroscopy ,Cell Proliferation ,antitumor ,Membrane Potential, Mitochondrial ,pectin ,Cell growth ,Chemistry ,Organic Chemistry ,neurodegeneration ,General Medicine ,phytochemicals ,In vitro ,Computer Science Applications ,mitochondria ,Neuroprotective Agents ,Pectins ,cell cycle ,Oxidative stress ,Citrus paradisi - Abstract
Tested in vitro on SH-SY5Y neuroblastoma cells, grapefruit IntegroPectin is a powerful protective, antioxidant and antiproliferative agent. The strong antioxidant properties of this new citrus pectin, and its ability to preserve mitochondrial membrane potential and morphology, severely impaired in neurodegenerative disorders, make it an attractive therapeutic and preventive agent for the treatment of oxidative stress-associated brain disorders. Similarly, the ability of this pectic polymer rich in RG-I regions, as well as in naringin, linalool, linalool oxide and limonene adsorbed at the outer surface, to inhibit cell proliferation or even kill, at high doses, neoplastic cells may have opened up new therapeutic strategies in cancer research. In order to take full advantage of its vast therapeutic and preventive potential, detailed studies of the molecular mechanism involved in the antiproliferative and neuroprotective of this IntegroPectin are urgently needed.
- Published
- 2021
- Full Text
- View/download PDF
13. Inflammation, genes and zinc in Alzheimer's disease
- Author
-
Vasto, Sonya, Candore, Giuseppina, Listì, Florinda, Balistreri, Carmela Rita, Colonna-Romano, Giuseppina, Malavolta, Marco, Lio, Domenico, Nuzzo, Domenico, Mocchegiani, Eugenio, Di Bona, Danilo, and Caruso, Calogero
- Subjects
- *
ALZHEIMER'S disease , *NEURODEGENERATION , *DISEASES in older people , *HUNTINGTON disease - Abstract
Abstract: Alzheimer''s disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Western society mainly accounts for clinical dementia. AD has been linked to inflammation and metal biological pathway. Neuro-pathological hallmarks are senile plaques, resulting from the accumulation of several proteins and an inflammatory reaction around deposits of amyloid, a fibrillar protein, Aβ, product of cleavage of a much larger protein, the β-amyloid precursor protein (APP) and neurofibrillary tangles. Amyloid deposition, due to the accumulation of Aβ peptide, is the main pathogenetic mechanism. Inflammation clearly occurs in pathologically vulnerable regions of AD and several inflammatory factors influencing AD development, i.e. environmental factors (pro-inflammatory phenotype) and/or genetic factors (pro-inflammatory genotype) have been described. At the biochemical level metals such as zinc are known to accelerate the aggregation of the amyloid peptide and play a role in the control of inflammatory responses. In particular, zinc availability may regulate mRNA cytokine expression, so influencing inflammatory network phenotypic expression. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
14. Glucagon-like peptide-2 reduces the obesity-associated inflammation in the brain
- Author
-
Sara Baldassano, Pasquale Picone, Marta Di Carlo, Flavia Mulè, Giacoma Galizzi, Domenico Nuzzo, Gaetano Felice Caldara, Antonella Amato, Nuzzo, Domenico, Baldassano, Sara, Amato, Antonella, Picone, Pasquale, Galizzi, Giacoma, Caldara, Gaetano Felice, Di Carlo, Marta, and Mulè, Flavia
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Inflammation ,medicine.disease_cause ,Diet, High-Fat ,Settore BIO/09 - Fisiologia ,Neuroprotection ,lcsh:RC321-571 ,03 medical and health sciences ,0302 clinical medicine ,Neuroinflammation ,Internal medicine ,medicine ,Glucagon-Like Peptide 2 ,Animals ,Obesity ,Neurodegeneration ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,TUNEL assay ,Glial fibrillary acidic protein ,biology ,Chemistry ,digestive, oral, and skin physiology ,Brain ,medicine.disease ,Mice, Inbred C57BL ,030104 developmental biology ,Endocrinology ,Neuroprotective Agents ,Neurology ,Gliosis ,Oxidative stress ,Astrocytes ,biology.protein ,Glucagon-Like Peptide-2 Receptor ,Oxidative stre ,Encephalitis ,medicine.symptom ,Inflammation Mediators ,GLP-2 ,030217 neurology & neurosurgery ,hormones, hormone substitutes, and hormone antagonists - Abstract
Growing evidence suggests a link between obesity and neurodegeneration. The purpose of the present study was to explore the neuroprotective potential of glucagon-like peptide-2 (GLP-2) in the brain of high fat diet (HFD)-fed mice. Markers of inflammation and oxidative stress were analysed in the brains of obese mice chronically treated with [Gly2]-GLP-2 (teduglutide), the stable analogue of the GLP-2, and they were compared to age-matched untreated obese and lean animals. Neurodegeneration was examined by TUNEL assay. HFD feeding increased the expression of pro-inflammatory mediators (NF-kB, IL-8, TNF-α, IL-1β and IL-6), glial fibrillary acidic protein (GFAP), index of gliosis and neurodegeneration, stress marker proteins (p-ERK, Hsp60 and i-NOS), amyloid-β precursor protein (APP). [Gly2]-GLP-2 treatment significantly attenuated the HFD-induced increased expression of the various markers, as well as the higher levels of reactive oxygen species found in brains of untreated-HFD mice. Immunofluorescence confirmed that the increase of GFAP or APP in the brain cortex of HFD mice were less prominent in the [Gly2]-GLP-2 treated group. TUNEL-positive cell number in brain sections of [Gly2]-GLP-2-treated HFD-fed mice was significantly lesser in comparison with untreated-HFD animals and similar to STD fed mice. In conclusion, the results of the present study suggest that GLP-2 stable analogue improves the obesity-associated neuroinflammation and the central stress conditions, it reduces the neuronal apoptotic death, providing evidence for a neuroprotective role of the peptide.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.